Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Eikesdal HP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nikolaienko O; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Eikesdal HP; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Ognedal E; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Lundgren S; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway., Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Geisler S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway., Yndestad S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Minsaas L; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Leirvaag B; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Lillestøl R; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway., Lønning PE; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway. per.lonning@helse-bergen.no.; Department of Oncology, Haukeland University Hospital, Jonas Lies Vei 65, N5021, Bergen, Norway. per.lonning@helse-bergen.no.
Publikováno v:
Genome medicine [Genome Med] 2023 Dec 06; Vol. 15 (1), pp. 104. Date of Electronic Publication: 2023 Dec 06.
Autor:
Yndestad S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Engebrethsen C; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Herencia-Ropero A; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Nikolaienko O; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Vintermyr OK; Department of Pathology, Haukeland University Hospital, Bergen, Norway.; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Lillestøl RK; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Minsaas L; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Leirvaag B; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Iversen GT; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Blix ES; Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Espelid H; Department of Surgery, Haugesund Hospital, Haugesund, Norway., Lundgren S; Cancer Clinic, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Aase HS; Department of Radiology, Haukeland University Hospital, Bergen, Norway., Aas T; Department of Surgery, Haukeland University Hospital, Bergen, Norway., Gudlaugsson EG; Department of Pathology, Stavanger University Hospital, Stavanger, Norway., Llop-Guevara A; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Serra V; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway., Lønning PE; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Knappskog S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway., Eikesdal HP; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Deceased.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Sep; Vol. 7, pp. e2300338.
Autor:
Lønning PE; K.G. Jebsen Centre for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Nikolaienko O; K.G. Jebsen Centre for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Pan K; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California., Kurian AW; Departments of Medicine and of Epidemiology and Population Health, Stanford University, Stanford, California., Eikesdal HP; K.G. Jebsen Centre for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Pettinger M; Division of Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington., Anderson GL; Division of Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington., Prentice RL; Division of Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington., Chlebowski RT; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California., Knappskog S; K.G. Jebsen Centre for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Publikováno v:
JAMA oncology [JAMA Oncol] 2022 Nov 01; Vol. 8 (11), pp. 1579-1587.